Several MANBA inhibitors have been developed as putative treatment against inborn lysosomal storage disorder caused by the deficient activity of beta-mannosidase, but it unclear whether this condition is related to ADHD-symptoms. The gene discussed is MANBA; the disease is attention deficit-hyperactivity disorder.